Profil

FELTEN Paul

Main Referenced Co-authors
LETELLIER, Elisabeth  (4)
HEURTAUX, Tony  (3)
HEUSCHLING, Paul  (3)
GRANDBARBE, Luc  (2)
Gustin, Audrey (2)
Main Referenced Keywords
Melanoma (2); ALK (1); Cell cycle checkpoints (1); Colon cancer stem cell (1); DNA damage response (1);
Main Referenced Unit & Research Centers
University of Luxembourg (1)
Main Referenced Disciplines
Biochemistry, biophysics & molecular biology (5)
Life sciences: Multidisciplinary, general & others (2)

Publications (total 7)

The most downloaded
159 downloads
Margue, C., Philippidou, D., Kozar, I., Cesi, G., Felten, P., Kulms, D., Letellier, E., Haan, C., & Kreis, S. (February 2019). Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells. Journal of Experimental and Clinical Cancer Research, 38 (1). doi:10.1186/s13046-019-1038-x https://hdl.handle.net/10993/40470

The most cited

281 citations (Scopus®)

Gustin, A., Kirchmeyer, M., Koncina, E., Felten, P., Losciuto, S., Heurtaux, T., Tardivel, A., Heuschling, P., & Dostert, C. (19 June 2015). NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes. PLoS ONE, 10 (6). doi:10.1371/journal.pone.0130624 https://hdl.handle.net/10993/26403

Ullmann, P., Nurmik, M., Schmitz, M., Rodriguez, F., Weilerr, J., Baig, K., Felten, P., Nazarov, P., NICOT, N., Zuegel, N., Haan, S., & Letellier, E. (May 2019). Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activity. Cancer Letters, 450, 32-41. doi:10.1016/j.canlet.2019.02.030
Peer Reviewed verified by ORBi

Margue, C., Philippidou, D., Kozar, I., Cesi, G., Felten, P., Kulms, D., Letellier, E., Haan, C., & Kreis, S. (February 2019). Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells. Journal of Experimental and Clinical Cancer Research, 38 (1). doi:10.1186/s13046-019-1038-x
Peer Reviewed verified by ORBi

Cesi, G., Philippidou, D., Kozar, I., Kim, Y. J., Bernardin, F., Van Niel, G., Wienecke-Baldacchino, A., Felten, P., Letellier, E., Dengler, S., Nashan, D., Haan, C., & Kreis, S. (2018). A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells. Molecular Cancer, (17:145). doi:10.1186/s12943-018-0886-x
Peer Reviewed verified by ORBi

Ullmann, P., Rodriguez, F., Schmitz, M., Meurer, S. K., Qureshi-Baig, K., Felten, P., Ginolhac, A., Antunes, L., Frasquilho, S., Zugel, N., Weiskirchen, R., Haan, S., & Letellier, E. (2018). The microRNA-371~373 cluster represses colon cancer initiation and metastatic colonization by inhibiting the TGFBR2/ID1 signaling axis. Cancer Research. doi:10.1158/0008-5472.CAN-17-3003
Peer Reviewed verified by ORBi

Hoenen, C., Gustin, A., Birck, C., Kirchmeyer, M., Beaume, N., Felten, P., Grandbarbe, L., Heuschling, P., & Heurtaux, T. (2016). Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant. PLoS ONE. doi:10.1371/journal.pone.0162717
Peer Reviewed verified by ORBi

Gustin, A., Kirchmeyer, M., Koncina, E., Felten, P., Losciuto, S., Heurtaux, T., Tardivel, A., Heuschling, P., & Dostert, C. (19 June 2015). NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes. PLoS ONE, 10 (6). doi:10.1371/journal.pone.0130624
Peer Reviewed verified by ORBi

Heurtaux, T., Michelucci, A., Losciuto, S., Gallotti, C., Felten, P., Dorban, G., Grandbarbe, L., Morga, E., & Heuschling, P. (July 2010). Microglial activation depends on beta-amyloid conformation: role of the formylpeptide receptor 2. Journal of Neurochemistry, 114 (2), 576-586. doi:10.1111/j.1471-4159.2010.06783.x
Peer Reviewed verified by ORBi

Contact ORBilu